A single pill each day could protect against heart attacks, strokes
January 5th, 2011 - 4:56 pm ICT by ANILondon, Jan 5 (ANI): A new single daily pill which could protect against heart attacks and strokes is being tested by a team at London’s Wolfson Institute, who will offer it to 100 patients for 12 weeks.
The all-in-one ‘polypill’ is a combination of a range of medicines to reduce cholesterol and blood pressure instead of patients having to take several tablets, reports the Daily Express.
The pill has low doses of the cholesterol drug simvastatin and low doses of three blood pressure drugs.
The idea was first suggested in 2003 when scientists said its widespread use “would have a greater impact on the prevention of disease in the western world than any other single intervention.”
If the latest trial turns out to be successful, the pill could be offered on prescription for the over 50s within two years. (ANI)
- Polypill 'a viable treatment option for patients at high risk of CVD' - Mar 22, 2011
- New polypill halves heart disease and stroke risk - May 26, 2011
- Statin 'could be the new wonder drug' - Nov 09, 2010
- Cholesterol-busting pill could save heart victims - Nov 18, 2010
- Olive leaf pill may help combat heart trouble - Apr 16, 2011
- Tomatoes can save you from high cholesterol - May 19, 2011
- Aspirin can do more harm than good for healthy people - Aug 31, 2009
- Splitting tablets a potentially dangerous practice: Study - Jan 06, 2011
- High BP responds better to combo therapy - Jan 13, 2011
- A jab could lower cholesterol by two-thirds - Nov 15, 2011
- Three-pill combo for high BP launched - Nov 22, 2011
- Combining two drugs treats blood pressure better - Jan 13, 2011
- BP drug could harm stroke patients - Feb 13, 2011
- Indian study shows 'five-in-one magic bullet' may halve heart problem incidences - Mar 31, 2009
- Beware! Pain killers could spike your BP - Mar 21, 2012
Tags: 50s, blood pressure drugs, cholesterol, cholesterol drug, daily express, heart attacks, london jan, medicines, polypill, prevention, scientists, simvastatin, wolfson institute